Gerry Brunk is listed as a director on 2 SEC Form D filings by 2 issuers between Nov 2020 and Oct 2022: PIC Therapeutics, Inc. (Natick, MA — biotechnology — 2022; $11.5M reported sold to 36 investors) and Cyrano Therapeutics, Inc. (Washington, DC — other health care — 2020; $4.08M reported sold to 11 investors).
What this means 2 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $15.6M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Gerry Brunk and found 8 differences: Bankruptcy case: Zaks v. Mosdos Chofetz Chaim Inc; Gerry Brunk appears on 2 deals that stopped filing before reaching their target; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.